ESLA ▲ +3.2% - Estrella Immunopharma, Inc. $ESLA Estrella Immunopharma Activates Intermountain Health LDS Hospital as Fifth Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma 14-OCT-2026 04:19 PM ET